PTAFR (platelet-activating factor receptor) expression was decreased after UVR, although activation of this receptor on melanoma cells has been demonstrated to enhance their proliferation, invasiveness, and metastatic capabilities [19]. The gene discussed is PTAFR; the disease is melanoma.